TAFLUPROST- tafluprost solution 
The Ritedose Corporation

----------

Tafluprost Ophthalmic Solution, 0.0015%

NDC 0781-6184-87

Tafluprost Ophthalmic Solution 0.0015%

Single-Use Containers

Preservative-Free, Sterile

For Topical Application in the Eye

REFRIGERATE (2° to 8°C or 36° to 46°F)

Rx Only

30 Single-Use Containers:

6 Pouches x 5 Single-Use Containers

(0.3 mL each)

Sandoz A Novartis Division

Tafluprost Ophthalmic Solution, 0.0015% Carton

tafluprost-30ct-carton

TAFLUPROST 
tafluprost solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:65302-062
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TAFLUPROST (UNII: 1O6WQ6T7G3) (TAFLUPROST - UNII:1O6WQ6T7G3) TAFLUPROST0.0045 mg  in 0.3 mL
Inactive Ingredients
Ingredient NameStrength
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
GLYCERIN (UNII: PDC6A3C0OX)  
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE (UNII: 5QWK665956)  
WATER (UNII: 059QF0KO0R)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:65302-062-056 in 1 CARTON12/05/2022
15 in 1 POUCH
10.3 mL in 1 AMPULE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20904012/05/2022
Labeler - The Ritedose Corporation (837769546)
Establishment
NameAddressID/FEIBusiness Operations
The Ritedose Corporation837769546analysis(65302-062) , label(65302-062) , manufacture(65302-062) , pack(65302-062)

Revised: 12/2022
Document Id: f05e2b3e-be98-5187-e053-2a95a90a1067
Set id: f05e2b3e-be97-5187-e053-2a95a90a1067
Version: 1
Effective Time: 20221221
 
The Ritedose Corporation